免费文献传递   相关文献

Preparation and characterization of ginsenoside-Rh2 lipid nanoparticles and synergistic effect with borneol in resisting tumor activity

人参皂苷Rh2脂质纳米粒的制备表征及冰片对其抗肿瘤活性的协同作用研究



全 文 :2016
y

z ³
41
ų

}
Vol41,No.7 April,2016

”•)(
] 20160115

–—˜R
] 
ì(81001650)

™x?š
] 


Ž

€®……ÝÞß$†à$
,Email:yanglincdu@126com

?š¢£
] 
”•



Ž

€®……!$$‡%¦$Uáâ%
,Email:zouliang@cdueducn
·
>]Ti>
·
$Ýéê
Rh2%Þ&(±Ë)*+Ê,-
ìÓô./ðµ±*¦0ž«¬
”•
1,
–—
1,

2,
™š
1,
/u{
1,

1
(1.
+°‘% #%q

³´ +°
610106;2.
+°‘% ³´Ýãäžå€’

³´ +°
610052)

›
] 
Ë)$Ýéê
Rh2%Þ&(,¬¦¤Ó*¦,-±°ðô./ðµ。˚?A»x½_gŒ,pžÕ›ïš˜Ãˆ
mË)$Ýéê
Rh2%Þ&(,¬ìÓR}‡、|,‡、(U—‹、ZetaUí、_ß、°ð,˜Ï;n•èÖn*+,MTTÌ
ͦ¤Ó*¦,-±ô./ðµ

͞½_gŒË)±&“À(¾¯u%

_ßÕ÷
,3
Þ%uR}‡•
(773±25)%,
|
,‡•
(72±02)%。,
°ð-Búh±yϖ+
,96h
ÄxÏ;
5242%;
$Ýéê
Rh2&(0ž24,48hìv`Þ/C6Za
°ðø™0ž±
IC50—`•2233,1146μmol·L
-1,
&(ÙÚ,-Y
IC50•1636,804μmol·L
-1,
¬Û±Å¾·=µ


œž
] 
$Ýéê

,-

&(

ô./
PreparationandcharacterizationofginsenosideRh2lipid
nanoparticlesandsynergisticefectwithborneolinresistingtumoractivity
ZOULiang1,FUJia1,LIWei2,YUTian1,GUOXiaoheng1,YANGLin1
(1.MedicalColege,ChengduUniversity,Chengdu610106,China;
2.SichuanIndustrialInstituteofAntibiotics,ChengduUniversity,Chengdu610052,China)
[Abstract] ToprepareginsenosideRh2lipidnanoparticles,andinvestigatethesynergisticefectwithborneolinresistingtumorac
tivityinvitroGinsenosideRh2lipidnanoparticleswerepreparedbyultrasonicassistedsolventevaporationmethod,andorthogonalde
signwasadoptedtooptimizeformulationprocessItsencapsulationeficiency,drugloadingratio,particlesizedistribution,Zetapoten
tial,morphologyandinvitrodrugreleasebehaviorwerecharacterized,andsynergisticefectwithborneolinresistingtumoractivity
werepreliminarilystudiedbyMTTThesenanoemulsionparticlespreparedbytheoptimizedprocessmethodwereroundingandevenin
agoodshapeEncapsulationeficiencyanddrugloadingratioofthreebatchesofnanoemulsionparticleswere(773±25)% and
(72±02)%,respectivelyNanoemulsionparticlesshowedanobvioussustainedreleasecharacteristics,with5242% cumulative
releasewithin96hThekilingefectofnanoemulsionparticlesongliomacelswasdosedependent,withIC50of2233μmol·L
-1
and1146μmol·L-1after24hand48h,respectivelyAfterthecombinationwithborneol,thekilingefectofnanoemulsionparti
clesongliomacelswasdosedependent,withIC50of1636μmol·L
-1and804μmol·L-1after24hand48h,respectively
[Keywords] ginsenosides;borneol;nanoparticles;antitumor
doi:10.4268/cjcmm20160713
  

PanaxginsengCAMeyer
É»%WÆ®T $,Š

-B…°~W

°W±#

8Œ±Õ±¥É

·5321·
2016
y

z ³
41
ų

}
Vol41,No.7 April,2016
,ž°Ï]

ÛB

­,I

±‘M

Ó$$Ýé
êÉ$Ý$L/Bɗ

±P«¬*ú

$Ýéê
-Bh·ô./

ôzõè,S0ž
[1],
Ó$$Ýé
ê
Rh2(ginsenosideRh2)–—É[º^ê~,-B
Óçô./0ž
[25],
ÓL/0žfËÉ@¸˜Ï®
|¥{

9Ë./±fg¬oy

\]ˆZaë/Ê
9Ë./¥Â¢3±_–

no./Za±s,µ

øe_ˆôˆ,˜±,É

\]ˆZa—_¬9ˈ
ZaÂË

ÁMak2p&t_ˆ±h£0žè

*
±de±‚žíÊ

}ʟ$Ýéê
Rh2¢˜µ
Ô

˜nž¾t

tG./ZaÝ*s±

£|}
ð…è–ë

…¹¾CËÓô./‚ž

ÎyÏ

¶&|°‚žŸ,˜ô./W¶«
¬$

°±dŠ…±½ß

Mh·TÙ,˜¢˜µ

øÅ,˜¿./F±62

#Ý./Za$,˜
ž

&ê,˜h£Ö‚è
[6]。
Àí




°

KV˜`o

&ÓÒ蕍&_óîÓԂ
žŸ$,ô./𵖗¶,«¬$

¬Ö<Õ÷
Éæ
[7],
}ÀíÁòêB«¬ì$Ýéê
Rh2Ön
&R|¬ô./±«¬

%ÞKV˜&(
[8]
É[¥Q±&|,°Å

1Ÿ%ފÌÑKV
˜ŠÌ±Õ÷˜8wµ

¶%Þ&(±ÝKâ
µÑKV˜8±½Õ|,µ{€œV

¦O-B
°8Ë=M0ž¬Ý³´ËYÒɂ
(enhanced
permeabilityandretentionefect,EPRefect)。

Ÿ¿¢v´D

]c‘ž,˜pü%Þ&(†
„ÖOv1Oû

Àí_ˆ ¨ìŸv1O ±
$ˆÉæ~BC

av`Þ/•P*±v1ÜO$
ˆéˆBɱ¶, ¨

,-É¢v?&Ž˜¢v?€%±#֘


9mÀ
》¨
|,-B

Í,÷n

ý¥É

¿í•
$–,$0•


”,
MaÖ,˜¸¢v´
D

0•v1O ±Í,

‚žŸvkl~,Å
Æ
[911]。
Àí«¬*ú,-Ñ,˜p&|,æV
˜”ž-BÖ,˜Ov¶Ñ±0ž
[1213]。

¬5ì$Ýéê
Rh2‘ž_󿢘µ¬ô./0
ž±¥Ð

pž%ÞKV˜&(¶ÓR|Ÿ8

<ä-Bôœ÷±&¶,ÅÆ

žaôv`Þ
/

¬Ñ,-*¦~,

aøeôv`Þ/Za0
ž

@¸¦¤$Ýéê
Rh2R|gŒ、S_µÞ¬
*¦,-Y&(±°ðôZaø™0ž

«¬Ó
0•v`Þ/$ˆ~, ¨±M{µ

1 
ŠÌ
METTELERAE200S
QUï—àË%

ˆ–$

3n•“wBCDE
);RTElite
—¶%ñ&w

‘%
ThermoScientific
DE
);NanoZSP
&(¾

Uí—à“

’%
Malvern
“wBCDE
);MilQ
Ջ¢“

‘%
Milpore
DE
);H600
Q´ÆUï
hÓ¯

{9
Hitachi
DE
);Waterse2695
Ýɤ€
(ç“

‘%
Waters
DE
);FH100
Q—GŸ¶•

‘%
ThermoScientific
DE
);SpectraMaxM5

“

‘%
MolecularDevices
DE
)。
$Ýéê
Rh2(‹¾≥98%,–†(––DE);
(+)
,-

‹¾≥98%,…Á‘)˜()BCD
E
);PEG2000DSPE
K€m¨A’5%

K8…*
˜&(BCDE
);PLGA
K

“¼

‚1m¼

”


Ò5š+˜ˤDE
);
|À,5%
(SIG
MAALDRICH
$%
);
v`Þ/
C6
ZaÔ

$%&
>÷HZa«¬b
);
«|}q

‘%
Gibco
D
E
);DMEM
Ý£4½¤

÷%}’\˜A,()
BCDE
);
ÓâÃu•—à‹

2 
œ
21 
$Ýéê
Rh2ëßáâ pž Waterse2695
HPLCUV
áâ$Ýéê
Rh2ëß。(ç” Waters
C18”(46mm×250mm,5μm),”¶25℃,‚áV
Ë
203nm,
G¶€¢


(40∶60),

10mL·
min-1。
~c¼Ö$Ýéê
Rh2ìH¤HߟßÁ
$

ž‡¨˜7¬âêŸO¾Ù–Ì)¤
01g·
L-1。
—`~c©Ö[âßÌ)¤Ù˖
100,50,
25,125,625,3125mg·L-1
ÅKÞßž±ìH
¤˜¤

á␑2

a‘2•i0Â

Þßž
•0Â

<›µ–•œ¹Ê›µÅ

¬¦¤{þ
¬{8~c¾

22 
%ÞKV˜&(±Ë)
 
pžÕ›ïš˜
ÈmË)&(

¶[âß|À,5%Ñ
PEGDSPE
˜Ÿêßr¢m¨$

yñ-ÅO¶¢

¢€

$

+,&[¨Oþ

[¶$Ýéê
Rh2Ñ
PLGA
ŠÌ”˜Ÿm«

÷€

$

՛Yyñ-Å
O%Þ¢˜¤$

,˜Õ›W+,&[¨Oþ

p
žÓo¹m“&=†%ÑáBf˜Ã
,¸ 045μm
Ä#

†%bR|,˜


022μmÄ#Xþ,<
u%±Ô“3&˜¤

¿Uàۃ1i÷

;Ö|À,5%Ñ
PEG
DSPE
ñ¨

$Ýéê
Rh2Ñ PLGAŠÌñ¨、÷€
·6321·
rvè

$Ýéê
Rh2%Þ&(±Ë)*+Ê,-ìÓô./ðµ±*¦0ž«¬
¬¢€°2ñ•¦¤àÛ

;ÖR}‡¬|,‡•
‰V~‰Â

‰.Å=u•
05,
pž?A»x½
_Ë)gŒ

23 
%ÞKV˜&(±*+
 
ÖHß&(˜¤
(1g·L-1)
-Ÿ©.÷

:L
10min
YžÄ-©
j

W-Å
20%
5/¼˜¤Ÿ©.÷ZÊ
5min,
•
̈j

ž´ÆUïhÓ¯¤&(_ß

pžˆ
3(¾áâ“áâ&(%u(U¬
Zeta


1ŸÓ&Ä#¸Ä†%‘ž,˜

—`©Ö
è°2¸ÄíY±&˜¤

Ø>°2
1∶1
ÅOm
«Õ›IÓ7“˜7

¬âêŸO¾

ÇϟVHÞ
ßž

Ÿ

Ô
r·min-1
žS
10min,

022μm
Ó&Ä#ĸ

áâÓ$$Ýéê
Rh2ëß,¹—`
<ä&($,˜ë߬0,uß

R}‡

&
($,˜Þß

0,uÞß
×100%。
¶÷g¸ÄY&(˜¤øj

~c¼.

¹<
ä¸ÄY&($,˜Ñ|°ŠÌ±uß

|,
‡

&($,˜Þß
/(
&($,˜Þß

|
°ŠÌÞß
)×100%。
24 
%ÞKV˜&(±°ð,˜Ï;
 
ž´à
áâ&($R|$Ýéê
Rh2±°ðÏ,–
µ

¶—ï/Òß
3500
±´àžgh¬LŸ¹º
¢$fÂÕ¸
24h。
—`Ö
2mL
&(˜¤¬‘
ž,˜˜¤

$Ýéê
Rh2˜7Ÿm¨ÑKtmB
1Í÷
(1∶1)
LŸ´àž$

œ¹Ò1


37℃
40mL
ë
01%
KtmBü¢Ò;¨U÷¼

2

80)
±
PBS
¤$

¬a
300r·min-1
%ñ&w
¥&

—`Ÿ
025,05,1,2,4,8,12,24,48,
72,96h
©Ö´àžð1˜¤
1mL,
|º°/èß
±zª¤
。HPLC
á⥦Oþëzª¤$,˜Å
¾

x-,˜±ëß

[-<Ä2Ï,­—=

25 
Za4½
 C6
Za4½Ÿ
DMEM
4½1

ë
45g·L-1
·¸£
、37g·L-1
!¼ýÌ
、10%
†í
¢ª
、1%
vL:¡1¼
、1%
ý¡ f
、100mg·L-1
öŽÛ¬
100mg·L-1
ՎÛ
)。
4½ÒJ
:37℃,
5% CO2¬m¬\¾90%。
26 
%ÞKV˜&(ÙÚ,-±ôv`Þ/Z
aø™0ž
 
—`ÖÂ˲ßÕ÷¬Ÿì=ÂË
}±R>`Þ/
C6
Za

ž
025%
«|}q
EDTA
¤6_

¬Öæ3ÐË)–UZa4¤

¶Za4¤
±Å¾˜¯•
5×104

/mL
zŸ
96
&T

|&°
2
100μLÌY¶4½TyO4½Z$,37℃,5%
CO2Êm¬\¾ÒJ@4½24hŸZa5ºY,©
%4½1

pžr¢ª41—`ÇϑžŽ}&
(

,-

$Ýéê—

$Ýéê&(

&(

10μmol·L-1,-蟥¦,˜Å¾,ÐY©Å
¾Ö¾¿x&$—`ÅOÇÏY#¤x
100μL,Ž
}4½10•ìH

|.æ

&

—`4½
24,48

Y©%4½1

x&ÅO
100μL4½1Çϱ
MTT
˜¤

·Ó
4h,
WÅO
100μLDMSO˜7–
±‡6

@¸q“
(570nm)
‚áZaø™ðñ

3 
Ͼ
31 
&(,˜R|gŒ±¦¤
 
ƒ$ʟ¥
˜Ÿ¢±‘ž$Ýéê
Rh2Ä#îG†%,§˜
Ÿ¢±1—à$Ýéê
Rh2¿¢$˜7¾t,Ñ|
OKV˜&($Þ߀ñ

M£F¥x
[1415],
Ý
x-R}‡Ê|,‡O

$Ýéê
Rh2˜Ÿ¢±1
—¥¦Ù¿8

Ø>kƒm±xàÛ¢%ì(U
òóò:

ÝaR}‡¬|,‡•~‰Â

àÛ¢
%]*
1,
çƒ8…Êœæ]*
2,
œÔ—à]*
3。
*
1 
$Ýéê
Rh2&(Ë)gŒ½;?AƒàÛ¢%*
Table1 Thefactorsandlevelsoforthogonalexperimentforop
timizingformulationprocessofpreparationginsenosideRh2nan
oparticle
¢%

|À,5%Ñ
PEGDSPE
ñ¨

Rh2ÑPLGA
ŠÌñ¨

÷¢
°2ñ
1 1∶3 1∶1 1∶3
2 1∶1 1∶2 1∶5
3 3∶1 1∶3 1∶8
*
2 
$Ýéê
Rh2&(Ë)gŒ½;?Aƒ8…Ê
Ͼ
Table2 Designandresultsoforthogonalexperimentforoptimi
zingformulationprocessofpreparationginsenosideRh2nanopar
ticle
No. A B C
R}‡
/%
|,‡
/%
‰V~—
1 1 1 1 154 218 1862
2 1 2 2 552 187 3694
3 1 3 3 674 161 4170
4 2 1 2 178 252 2141
5 2 2 3 463 174 3184
6 2 3 1 715 182 4472
7 3 1 3 192 301 2461
8 3 2 1 513 176 3445
9 3 3 2 775 72 4236
·7321·
2016
y

z ³
41
ų

}
Vol41,No.7 April,2016
*
3 
‰V~—œÔ—à
Table3 Analysisofvarianceofoveralrating
œÔÏ> žÔ%œ¬ uœ
F P
A 3285 1642 0105 0904
B 695592 347796 22374 0042
C 1678 0839 0054 0948
ÄÔ
31088 15544
  
å
:f=2。
Ê6—àM

xàÛìË)gŒ±òów
™•
B>A>C。
œÔ—àœæ*ú

àÛ

ì‰V
~—Bh·µÔÕ

§àÛ

¬

ì~—òórh
·µÔÕ

ÝîâQ½gŒV•
A3B3C2,¹,5

PEGDSPE
ñ¨•
3∶1,Rh2Ñ PLGAñ¨•
1∶3,
÷¢€°2ñ¨•
1∶5。
©HQ­œ¬gŒÒJË)
Rh2%ÞKV˜
&(

Ön

º.æƒ

œæÓR}‡•
(773±25)%,
|,‡•
(72±02)%。
32 
|,&(±Þß~
 
Ó&Ä#¸Äí±
¤ß°Åÿ®ª(“3

F78

B­!M]±Z:
Ó(4ŸÓ$

:L
2h
8uàdZ:WI

ô$Y
¥{u%—J

§
022μmÓ&Ä#¸ÄY¤
߰ŕԮª(“3±

u%±1´ú`°˜¤

r­!M]ZÀ(

:L
72h
YrWIàd

@¸´ÆU¯M¤ä|,Ó(…1—–‹{
±Ò_

*‘193–

…:19u%

&(ýþ
19r3Á

pžˆ3JƓáâÓ|,&(%
u(U•
(964±36)nm,PDI
•
024±006,
U
í•
(-86±06)mV,
]q
1。
q
1 
$Ýéê
Rh2%ÞKV˜&(±´ÆU¯q(A)Ê(Uáâqi(B)
Fig1 GinsenosideRh2lipidpolymernanoparticlesunderTEM(A)andparticlesizedeterminationpicture(B)
33 
|,&(±°ðÏ,n•
 
$Ýéê
Rh2
¦‘ž˜¤$DöÏ;

¿
24h
ý8¹säÏ;%
0

uÏ,ßs
92%,
]q
2。
§|,&(±Ï;
{ŽÅyñ

ÓÏ;.›M—

§¨

6ϧ¨¬
KâÏ;§¨

¿6ϧ¨$

Ó(Ï;,ß¿
24

8sä
3964%,
ÐY¿qJ§¨+,OþQË

Ï,ßd+KâøË
,96h
Ä2Ï,ßsä
5242%,
¬ÛÑU÷ÜÞß

34 
|,&(±ôv`Þ/Zaø™0ž
 
$
Ýéê
Rh2¥¦_ó¿ÅKž@¥¦0žOþì
v`Þ/
C6
°ðø™0ž±òó

Ͼ]q
3,4。
q

Ͼhi

Ž}ŠÌ¬‘ž,-ì
C6
Za±ø
™rúh9Ë0ž

Êq

œæM
,3
$Ýé
ê
Rh2~,_óì C6Zaø™uÛ9Ë0ž,¬
۱ž¬Oþ·=µ

å¿xOþë±ôZa
  
q
2 
$Ýéê
Rh2¦˜¤$ÊÓ&($±°ðÏ;.›
Fig2 InvitrodrugreleaseprofilesofginsenosideRh2fromso
lutionandtheloadednanoparticles
ø™0žeðu•&

,-

U&(

‘ž
$Ýéê
Rh2。‘ž$Ýéê Rh20ž24,48h±
IC50—`• 3091,1913μmol·L
-1,
Ó&(±
·8321·
rvè

$Ýéê
Rh2%Þ&(±Ë)*+Ê,-ìÓô./ðµ±*¦0ž«¬
IC50—`• 2233,1146μmol·L
-1,
&(ÙÚ
,-Y
IC50•1636,804μmol·L
-1,
Êïéúp
ž%ÞKV˜&(R|$Ýéê
Rh2Y,Múh
øÅÓô./0ž

¦OÙÚ,-Y

Óô./0
žøe

4 
Ús
$Ýéê•%˜µ–—

Àí&~,ÅƂ
žŸ$Ýéê±kÚÁ¥•

O]›$Ýéê
Rh2,
Rh3,CK±æV&“Ã
[16],
$Ýuéê5%æV
˜RkÓ9
[17],
$Ýéê
Rh3&Ó(
[18],
}|}
  
A
Ž}
;B
,-

q
3 
Ž}&(¬,-ì
C6
Zaø™±òó
Fig3 Efectsofblanknanoparticlesandborneolontheprolif
erationofC6cel
A24h;B48h。
q
4 
Ýéê
Rh2‘ž_ó、&(aÊÙÚ,-ìC6Zaø™±òó
Fig4 EfectsoffreeginsenosideRh2,nanoparticlesandcombinationborneolontheproliferationofC6cel
&ÓÒ
[19],
$Ýéê
Rg
>°%Þ&(
[20]
è

9çƒpžÕ›˜ÃˆmË)%ÞKV˜&(
žaR|$Ýéê
Rh2。¿Ë)gŒ$,ÐÓPLGA
KV˜Å¾±¥øÅ

UíÞß&(MR:Ž
•±$Ýéê

}ï̱øÅM{ì–|,ßät

ba‰V~—$;qR}‡Ê|,ß0•~‰
Â

§Ë)¸¹Ð¢€°2øÅ

R}‡Ê|,ß
uät

ràM{É¢€°2øÅ

Bf€qJä¢
€±ö¾ÅD

§KV˜R|Ÿ%Þû:/[âO
þ

,˜Ï¥ÊGKV˜R|&ÐBf€qJä¢
€$

ÝR}‡Ê|,ßuät

‰V~—ät

$Ýéê
Rh2Œá˜nž¾„t,ÓL/r
àRSŒáYù²Ú©ª±,ßê

tG6_Ú
±qpÓ˜—7

‚¾±H¸É‚úh

¶$Ý
éê
Rh2˖%ÞKV˜&(Y,By¶ÓË)
0•Œá~,

|,&(ŒáY

Mnž%Þ
û±3صøÅ|,(￲ڱóÒOþ¬z;
‘2

TÙ,˜¿²Ú$±—‹¬W¶

#݌áÂ
˜nž¾

¦O

,˜R:YÏ,yñ

¦O&
(ôœ÷Mde,˜®ãù²Ú6_q±ä7

¬ç±yñ+,FÏ;,˜

Ö,˜±²Ú©ª

«¬œæŠç

a%ÞKV˜&(•|°R
|$Ýéê
Rh2Y{BÉøŖ—±¢˜µ,Ó(
U—‹u[

_ß¾¯

¬å-B,˜yϖ+

¦
O°ð«¬*ú&(MøÅìv`Þ/Zaø™
9Ë0ž

,-Mõö´¸¢v´D

-B
“´
n
{ßð

³I{B¥
”、“
±?ô<

Í,÷n

±–
ë

H*Ñâ,ÙÚ

í•$–,

›8}íÀ9

=?dS9¬,?Jè†B,-±Ùڂž


ƒ¶,-Ñ$Ýéê
Rh2&(ÙÚIža}øÅ
&(ôv1./Éæ

œæ*ú

UV~,Y$Ý
éê&(±ô./0žh·øÅ

éú’~,
œóM{0•ôv1./±BÉ,˜W¶TU


„q=

[1] 
IH9

$Ýéê,S«¬Ö×
[J].
$%…†,SÑ$
ˆ
,2006,11(11):1201.
·9321·
2016
y

z ³
41
ų

}
Vol41,No.7 April,2016
[2] 
!KI

Ÿ¬

$Ýéê
Rh2ô./0žf˱«¬Ö×
[J].
8§Ð)&
,2008,36(4):1467.
[3] 






è

$Ýéê
Rh2ÊÓ`˜±«¬Ö
×
[J].
’“&()
———
$A,±P_
,2012,14(6):
2205.
[4] 
Ô&&

M>

$Ýéê
Rb1、Rg3、Rh2ô./0žÑf˯
Ÿ
[J].
’“&()
———
$A,±P_
,2013,15(7):
1634.
[5] 
PÎ(

²€±

EV

è

$Ýéê
Rh2ô./0ž«¬
Ö×
[J].
,Ö×
,2007,10(3):236.
[6] 
ønû

øÆa

&(0•ô./,˜|°±«¬Ö×
[J].
$%./…†
,2013,40(6):363.
[7] 
¦?8

¶’

{z

è

KV˜&(ï0•ô./,˜
|°±‚ž
[J].
$,
,2007,38(8):1265.
[8] BivashM,HimanshuB,NiveshM,etal.Coresheltypelipid
polymerhybridnanoparticlesasadrugdeliveryplatform[J].
Nanomedicine,2013,9(4):474.
[9] 
Fn:

!|<



è

,-ÑÜ¢¼

¬Lýuéê
ÙÚìo@µvé¢

WÆå…Rv
VEGFmRNA
*s±ò
ó
[J].
$%$KAœVïA-.
,2005,12(5):263.
[10] 
m^©



EA3

,-¿v1ÜO$±‚ž
[J].
T
™$A>k
,2010,32(1):59.
[11] 
Bve

!Õv

îHL

è

,-ÖBô¸¢v´D
烫¬
[J].
$ƌð&ÜO«¬-.
,2007,6(3):
244.
[12] RenJG,ZouMJ,GaoP,etal.Tissuedistributionofborneol
modifiedganciclovirloadedsolidlipidnanoparticlesinmiceafter
intravenousadministration[J].EurJPharmBiopharm,2013,
83:141.
[13] 
{u

?
EfC

è

®¼ã°×]±ô./,˜«
¬Ö×
[J].
,k
,2009,44(2):109.
[14] 
ñ©’

ŸuD

%Ó{
.PLAmPEG
±V–¬•KÜE¨
KV˜`o±Ë)
[J].
$%,&…k
,2008,39(3):
223.
[15] ZhangJM,ZhangM,JiJ,etal.Glycyrhetinicacidmediated
polymericdrugdeliverytargetingtheacidicmicroenvironmentof
hepatocelularcarcinoma[J].PharmRes,2015,32(10):3376.
[16] 
ø5H

!çˆ

IôÆ

è

ëB$Ýéê±&“ÃÊ
ÓË)œ¬žT

$%
,CN200410064384.X[P].2005
0615.
[17] 
yA-

I5Ñ

—|K

è

$Ýuéê5%æV˜Rk
Ó9±Ë)
[J].
$%,-.
,2003,38(6):438.
[18] 


Ptg

9¦,
è

$Ýéê
Rg3¬PEGPLGARg3
&Ó(ì$¢38AZaGH¬Ó3_–{ñ±òó
[J].
23$A,…k
,2014,37(9):611.
[19] 
¹HI

Eâê

$Ýéê}|}&ÓÒì$#Xˆ
A549
ZaÂË9Ë0ž«¬
[J].
¡¢ìA
,2014,38
(10):1138.
[20] 
\h

®€L

!-m

è

$Ýéê
Rd
>°%Þ&(
±°ðÏ;¬…R±¿°©ª
[J].
$%,S@k
,2009,
25(7):923.

€-0
 
¤¥¥

·0421·